These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 32044168)
1. Neoadjuvant treatment strategies for resectable pancreas cancer: A propensity-matched analysis of the National Cancer Database. Xiang M; Heestand GM; Chang DT; Pollom EL Radiother Oncol; 2020 Feb; 143():101-107. PubMed ID: 32044168 [TBL] [Abstract][Full Text] [Related]
2. Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation. Zhong J; Patel K; Switchenko J; Cassidy RJ; Hall WA; Gillespie T; Patel PR; Kooby D; Landry J Cancer; 2017 Sep; 123(18):3486-3493. PubMed ID: 28493288 [TBL] [Abstract][Full Text] [Related]
4. Conventionally fractionated radiation therapy versus stereotactic body radiation therapy for locally advanced pancreatic cancer (CRiSP): An international systematic review and meta-analysis. Tchelebi LT; Lehrer EJ; Trifiletti DM; Sharma NK; Gusani NJ; Crane CH; Zaorsky NG Cancer; 2020 May; 126(10):2120-2131. PubMed ID: 32125712 [TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant Stereotactic Body Radiotherapy After Upfront Chemotherapy Improves Pathologic Outcomes Compared With Chemotherapy Alone for Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma Without Increasing Perioperative Toxicity. Hill CS; Rosati LM; Hu C; Fu W; Sehgal S; Hacker-Prietz A; Wolfgang CL; Weiss MJ; Burkhart RA; Hruban RH; De Jesus-Acosta A; Le DT; Zheng L; Laheru DA; He J; Narang AK; Herman JM Ann Surg Oncol; 2022 Apr; 29(4):2456-2468. PubMed ID: 35129721 [TBL] [Abstract][Full Text] [Related]
6. Stereotactic body radiotherapy for locally-advanced unresectable pancreatic cancer-patterns of care and overall survival. Dohopolski MJ; Glaser SM; Vargo JA; Balasubramani GK; Beriwal S J Gastrointest Oncol; 2017 Oct; 8(5):766-777. PubMed ID: 29184680 [TBL] [Abstract][Full Text] [Related]
7. Patterns of Failure Following Preoperative Chemotherapy and Stereotactic Body Radiation Therapy and Resection for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer. Libbey N; Gallagher L; Cantalino J; Weinberg BA; Noel MS; He AR; Radkani P; Marshall JL; Weiner LM; Jackson PG; Fishbein TM; Winslow ER; Haddad N; Rashid A; Unger KR J Gastrointest Cancer; 2024 Jun; 55(2):852-861. PubMed ID: 38347342 [TBL] [Abstract][Full Text] [Related]
8. Multiagent Chemotherapy Followed by Stereotactic Body Radiotherapy Versus Conventional Radiotherapy for Resected Pancreas Cancer. Mokhtech M; Miccio JA; Johung K; Cecchini M; Stein S; Narang AK; Herman JM; Kunstman J; Haddock MG; Anker CJ; Jabbour S; Hallemeier CL; Jethwa KR Am J Clin Oncol; 2022 Nov; 45(11):450-457. PubMed ID: 36318696 [TBL] [Abstract][Full Text] [Related]
9. Lymphocyte-sparing effect of stereotactic body radiation therapy compared to conventional fractionated radiation therapy in patients with locally advanced pancreatic cancer. Wu G; Baine MJ; Zhao N; Li S; Li X; Lin C BMC Cancer; 2019 Oct; 19(1):977. PubMed ID: 31640607 [TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma. Mellon EA; Hoffe SE; Springett GM; Frakes JM; Strom TJ; Hodul PJ; Malafa MP; Chuong MD; Shridhar R Acta Oncol; 2015 Jul; 54(7):979-85. PubMed ID: 25734581 [TBL] [Abstract][Full Text] [Related]
12. Association of survival with stereotactic body radiation therapy following induction chemotherapy for unresected locally advanced pancreatic cancer. Ma SJ; Serra LM; Bartl AJ; Han HR; Fekrmandi F; Iovoli AJ; Prezzano KM; Hermann GM; Yu H; Singh AK J Radiother Pract; 2022 Sep; 21(3):403-410. PubMed ID: 36016862 [TBL] [Abstract][Full Text] [Related]
13. Stereotactic body radiation therapy versus conventionally fractionated radiation therapy for early stage non-small cell lung cancer. Haque W; Verma V; Polamraju P; Farach A; Butler EB; Teh BS Radiother Oncol; 2018 Nov; 129(2):264-269. PubMed ID: 30031630 [TBL] [Abstract][Full Text] [Related]
14. Stereotactic body radiotherapy versus conventional radiotherapy for early-stage small cell lung cancer. Newman NB; Sherry AD; Byrne DW; Osmundson EC J Radiat Oncol; 2019 Jun; 8(2):239-248. PubMed ID: 31402969 [TBL] [Abstract][Full Text] [Related]
15. Perioperative outcomes and survival following neoadjuvant stereotactic body radiation therapy (SBRT) versus intensity-modulated radiation therapy (IMRT) in pancreatic adenocarcinoma. Chapman BC; Gleisner A; Rigg D; Meguid C; Goodman K; Brauer B; Gajdos C; Schulick RD; Edil BH; McCarter MD J Surg Oncol; 2018 Apr; 117(5):1073-1083. PubMed ID: 29448308 [TBL] [Abstract][Full Text] [Related]
16. Stereotactic body radiotherapy for unresected pancreatic cancer: A nationwide review. de Geus SWL; Eskander MF; Kasumova GG; Ng SC; Kent TS; Mancias JD; Callery MP; Mahadevan A; Tseng JF Cancer; 2017 Nov; 123(21):4158-4167. PubMed ID: 28708929 [TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant chemotherapy and stereotactic body radiation therapy for borderline resectable pancreas adenocarcinoma: influence of vascular margin status and type of chemotherapy. Palm RF; Boyer E; Kim DW; Denbo J; Hodul PJ; Malafa M; Fleming JB; Shridhar R; Chuong MD; Mellon EA; Frakes JM; Hoffe SE HPB (Oxford); 2023 Sep; 25(9):1110-1120. PubMed ID: 37286392 [TBL] [Abstract][Full Text] [Related]
18. Impact of neoadjuvant chemotherapy and stereotactic body radiation therapy (SBRT) on R0 resection rate for borderline resectable and locally advanced pancreatic cancer. Zakem SJ; Mueller AC; Meguid C; Torphy RJ; Holt DE; Schefter T; Messersmith WA; McCarter MD; Del Chiaro M; Schulick RD; Goodman KA HPB (Oxford); 2021 Jul; 23(7):1072-1083. PubMed ID: 33277184 [TBL] [Abstract][Full Text] [Related]
19. Pattern of Marginal Local Failure in a Phase II Trial of Neoadjuvant Chemotherapy and Stereotactic Body Radiation Therapy for Resectable and Borderline Resectable Pancreas Cancer. Kharofa J; Mierzwa M; Olowokure O; Sussman J; Latif T; Gupta A; Xie C; Patel S; Esslinger H; Mcgill B; Wolf E; Ahmad SA Am J Clin Oncol; 2019 Mar; 42(3):247-252. PubMed ID: 30724781 [TBL] [Abstract][Full Text] [Related]
20. Five-Fraction Stereotactic Body Radiation Therapy (SBRT) and Chemotherapy for the Local Management of Metastatic Pancreatic Cancer. Lischalk JW; Burke A; Chew J; Elledge C; Gurka M; Marshall J; Pishvaian M; Collins S; Unger K J Gastrointest Cancer; 2018 Jun; 49(2):116-123. PubMed ID: 28044263 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]